Travere Therapeutics TVTX

$ 34.75 -0.23%

Quarterly report 2025-Q2
added 08-06-2025

Country	USA
IPO year	-
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	74.3 M
Market Cap^[1]	$ 2.58 B
EBITDA (LTM)	$ -132 M
P/E (LTM)	-15.68
P/S (LTM)	8.25
EPS (LTM)	-2.22

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.